Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Glioblastoma 28Glioma 20Brain Neoplasms 18Astrocytoma 13Neuroblastoma 12Lung Neoplasms 11Breast Neoplasms 10Medulloblastoma 9Central Nervous System Neoplasms 9Osteosarcoma 7Carcinoma, Non-Small-Cell Lung 7Wilms Tumor 6Lymphoma, Non-Hodgkin 6Hepatoblastoma 6Ependymoma 6Rhabdoid Tumor 5Neuroectodermal Tumors, Primitive, Peripheral 5Meningioma 5Meningeal Carcinomatosis 5Melanoma 5Histiocytosis, Langerhans-Cell 5Gliosarcoma 5Sarcoma 4Rhabdomyosarcoma 4Prostatic Neoplasms 4Pheochromocytoma 4Paraganglioma 4Neoplasm Metastasis 4Ganglioneuroblastoma 4Thyroid Neoplasms 3

Interventions

Genetic Testing 2motexafin gadolinium 1Specimen Handling 1Genetic Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urogenital Neoplasms × Specimen Handling × CNS × Clear all
NCT04067960 2024-08-14

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

Mayo Clinic

Phase EARLY_PHASE1 Completed
197 enrolled
CNSGastrointestinalGenitourinaryGynecologic

Brain Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡